Bucks, United Kingdom

Stefano Ferrari

This inventor holds 1 USPTO granted patent. Top assignee: Roche Diagnostics Operations, Inc.. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stefano Ferrari. Retrieved from https://idiyas.com/inventor/stefano-ferrari-un1syob3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Stefano Ferrari

Introduction

Stefano Ferrari is a notable inventor based in Bucks, GB. He has made significant contributions to the field of medical diagnostics, particularly in the determination of glucose concentration in tissue fluid. His innovative approach has the potential to enhance the accuracy of glucose monitoring, which is crucial for diabetes management.

Latest Patents

Stefano Ferrari holds a patent for a method that determines glucose concentration in tissue fluid. This invention involves detecting test values for glucose and an endogenous reference substance in a sample liquid obtained through microdialysis, microperfusion, or ultrafiltration. The glucose value is then corrected based on the reference substance's test value. Additionally, the recovery rate for glucose is determined from a non-linear relationship with the recovery rate for the ionic reference substance, allowing for further corrections using lactate and/or pyruvate as additional reference substances.

Career Highlights

Stefano Ferrari is currently employed at Roche Diagnostics Operations, Inc., where he continues to work on innovative solutions in the field of diagnostics. His expertise and dedication to improving medical technology have made him a valuable asset to his team.

Collaborations

Stefano collaborates with talented professionals such as Ortrud Quarder and Peter Stephan. Their combined efforts contribute to the advancement of diagnostic methods and technologies.

Conclusion

Stefano Ferrari's work exemplifies the impact of innovation in medical diagnostics. His patent for determining glucose concentration in tissue fluid showcases his commitment to improving healthcare solutions. Through his career at Roche Diagnostics Operations, Inc., he continues to push the boundaries of technology in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…